Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis

OBJECTIVES: To examine company characteristics associated with better transparency and to apply a tool used to measure and improve clinical trial transparency among large companies and drugs, to smaller companies and biologics. DESIGN: Cross-sectional descriptive analysis. SETTING AND PARTICIPANTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Axson, Sydney A, Mello, Michelle M, Lincow, Deborah, Yang, Catherine, Gross, Cary P, Ross, Joseph S, Miller, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Ethics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291313/
https://www.ncbi.nlm.nih.gov/pubmed/34281933
http://dx.doi.org/10.1136/bmjopen-2021-053248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291313/
https://www.ncbi.nlm.nih.gov/pubmed/34281933
http://dx.doi.org/10.1136/bmjopen-2021-053248

Ejemplares similares